Spire Healthcare Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Spire Healthcare Group generated cash of $199,900,000, which is more than the previous year. Cash used in financing activities reached the amount of -$82,900,000 last year. Net change in cash is therefore -$24,600,000.
Cash Flow
| 2014 | 113M | -70M | -80M |
|---|---|---|---|
| 2015 | 155.3M | -109.6M | -41.3M |
| 2016 | 177.4M | -149.9M | -38.5M |
| 2017 | 124M | -118.3M | -34.4M |
| 2018 | 182.6M | -68M | -106.1M |
| 2019 | 184.5M | -48.8M | -92.6M |
| 2020 | 141.7M | -46.4M | -79.8M |
| 2021 | 170.6M | -48.3M | -26M |
| 2022 | 160.5M | -98M | -190.9M |
| 2023 | 199.9M | -157.2M | -82.9M |
SPI.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 74.2M | 202.6M | 106.3M | 90.8M | 47.7M | 39.2M | 67.9M | 78.9M | 74.5M | 111.5M |
Operating activities | ||||||||||
Net income | 27.3M | 8.6M | -9.7M | -233.9M | 7.2M | 100K | 16.8M | 53.6M | 60M | 6M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 103.6M | 97.9M | 97.1M | 94M | 91.6M | 88.9M | 57.4M | 51.9M | 48.9M | 45.1M |
Stock-based compensation expense | 4.09M | 2.3M | 2.8M | 1.7M | 1M | 500K | 1M | 400K | 700K | 2.8M |
| Deferred income tax benefit | 4.09M | 2.3M | 2.8M | 1.7M | 1M | 500K | 1M | 400K | 700K | 2.8M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -12.7M | -6.9M | 1.7M | -15.5M | 8.1M | 4M | 14.6M | 15.6M | 11.7M | -9.3M |
Inventories | -3.7M | -400K | -1.9M | -5.6M | -2.6M | 700K | -2M | 900K | -3M | 1.5M |
Accounts payable | 2.2M | 8.19M | 14.3M | 18.5M | 15.7M | 4.5M | 1.3M | 6.8M | -4.4M | 0 |
Cash generated by operating activities | 199.9M | 160.5M | 170.6M | 141.7M | 184.5M | 182.6M | 124M | 177.4M | 155.3M | 113M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 7.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -84.4M | -87.7M | -69.3M | -46.6M | -60.6M | -73.7M | -119.2M | -149.5M | -109.5M | -66.59M |
Acquisitions Net | -73.2M | -10.8M | -14.6M | 0 | 200K | 5.5M | 800K | 0 | 0 | -38.5M |
Cash generated by investing activities | -157.2M | -98M | -48.3M | -46.4M | -48.8M | -68M | -118.3M | -149.9M | -109.6M | -70M |
Financing activities | ||||||||||
Common Stock Issued | -600K | 3.1M | 0 | 0 | 0 | 0 | 0 | -1.8M | 0 | 317.2M |
Payments for dividends | -2M | -100K | 0 | 0 | -15.2M | -15.2M | -15.2M | -14.8M | -12.4M | 0 |
Repurchases of common stock | -3.1M | 0 | 0 | 0 | 0 | 0 | 0 | -1.8M | -5.6M | 0 |
Repayments of term debt | 40M | -100M | -14.7M | -13.4M | 0 | -17.1M | -400K | -400K | -800K | -805M |
Cash used in financing activities | -82.9M | -190.9M | -26M | -79.8M | -92.6M | -106.1M | -34.4M | -38.5M | -41.3M | -80M |
Net Change In Cash | -24.6M | -128.4M | 96.3M | 15.5M | 43.1M | 8.5M | -28.7M | -11M | 4.4M | -37M |
Cash at end of period | 49.6M | 74.2M | 202.6M | 106.3M | 90.8M | 47.7M | 39.2M | 67.9M | 78.9M | 74.5M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |